Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ) on the 1st of October 2020

01/10/2020

At the extraordinary General Meeting in Magle Chemoswed Holding AB, held on 1 October 2020, by way of the postal voting procedure the following main resolutions were passed:

  • Joel Eklund was elected as new member of the Board until the end of general meeting 2021.
  • The proposed remuneration for the new member of the Board of Directors was approved.

Minutes from the Extraordinary General Meeting with complete resolutions will be made available at Magle Chemoswed’s website: www.maglegroup.com

Chairman of the Board and major shareholder, Hans Henrik Lidgard, comments:

“Joel Eklund will enrich the board work in Magle Chemoswed Holding AB (publ) with his experience from industrial operations and his good relations with the business community in Skåne.”

Contacts

Justin Pierce, CEO, phone +46 (0)70 593 58 21, justin.pierce@maglegroup.com

About Us

We are Magle Chemoswed, a Malmö-based contract development and manufacturing organization (CDMO) that serves companies in the pharmaceutical and medical device industry on a contract basis. We provide comprehensive services from product development through product manufacturing and we pride ourselves in coming up with solutions to complex healthcare challenges. Together with our customers, we take innovations from idea to product. Learn more on www.maglegroup.com.

Västra Hamnen Corporate Finance is the Company's certified advisor on Nasdaq First North Growth Market and can be reached at ca@vhcorp.se or +46 (0) 40 200 250.

Attachments

Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ) on the 1st of October 2020